Clinical Research Associate

Salary: £33,100 per annum. The salary is subject to comparable skills and experience. Future progression is based on annual performance review.

Duration of Contract: Fixed Term for 12 months

Hours per week: 35 hours per week (Full Time)

Closing Date: 30th November 2025

The Institute of Cancer Research is looking for a Clinical Research Associate to join The Drug Development Unit (DDU) in our Investigator-Initiated Trials team based in Sutton, Greater London.

The Unit also has a portfolio of investigator-initiated phase 1 trials of novel targeted agents and combinations of these, including those made available via Cancer Research-UK's (CRUK) Experimental Cancer Medicine Centres (ECMC) Combinations Alliance. These studies are centrally managed by the Investigator Initiated Trials team - a dedicated team within the DDU that performs those functions associated with sponsoring early phase trials including project management, monitoring, pharmacovigilance, database development and central data review. The successful applicant will be responsible for monitoring allocated Phase I clinical trials to ensure compliance with GCP and the UK Clinical Trials legislation.

Key Requirements

The successful applicant should be a graduate in a life science or health related subject and understand Good Clinical Practice and the drug development process, particularly Phase I clinical trials. Excellent interpersonal skills are required, as is the ability to work to high standards across a variety of tasks with constant regard to scientific and regulatory requirements. Prior experience is not essential but experience of working in a clinical trial setting is desirable.

We encourage all applicants to access the job pack attached for more detailed information regarding this role.

Appointments will be on a one-year contract in the first instance. To apply for this post, please submit a CV and complete a supporting statement detailing reasons why you are applying for the post. All applications must be submitted online, via the e-recruitment system. Please click on the apply button and follow the instructions.

Due to the high volumes of applications we receive, we reserve the right to close the advert before the published closing date once we have received a sufficient number of applications. Therefore, we advise that you to submit your application, as early as possible to avoid disappointment.

Department/Directorate Information

The Drug Development Unit, (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, is a world-leading centre for early-phase oncology trials, translating cutting-edge science into first-in-human clinical trials.

Through close integration of laboratory and clinical expertise, the Unit supports the functions of sponsoring early phase trials through Investigator Initiated Trials Team, as well as delivers academic and industry sponsored trials.

Our mission is to fast-track the development of anti-cancer drugs, designed and synthesised at The ICR, or developed by CRUK scientists, or developed by industry collaborators, in order to rapidly impact the care of cancer patients. The DDU has been involved in the development of many hundreds of novel agents including several practice-changing cancer drugs.

The DDU is one of the Experimental Cancer Medicine Centres in the UK, part of the CRUK Convergence Science Centre and the Early Phase Drug Development Theme within the ICR-RM NIHR Biomedical Research Centre (BRC). The DDU has multiple academic and industry collaborations both nationally and internationally, to optimally serve our patients. The Unit is led by Professor Johann de Bono and Professor Udai Banerji.

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.